These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Ketazone hepatosis--a possibility for the development of secondary hypouricemia]. Heidelmann G; Porst H; Liebscher K Z Arztl Fortbild (Jena); 1986; 80(1):17-8. PubMed ID: 3754366 [No Abstract] [Full Text] [Related]
6. [Clinical findings and therapy of gout]. Böhme A; Altus RE Z Arztl Fortbild (Jena); 1969 Jun; 63(12):637-41. PubMed ID: 5812377 [No Abstract] [Full Text] [Related]
7. Preliminary studies with azapropazone in gout and hyperuricaemia. Thomas AL; Majoos FL; Nuki G Eur J Rheumatol Inflamm; 1983; 6(2):149-54. PubMed ID: 6673978 [TBL] [Abstract][Full Text] [Related]
8. [On gout]. Schulze H Munch Med Wochenschr; 1966 Jan; 108(2):96-8. PubMed ID: 6013450 [No Abstract] [Full Text] [Related]
9. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis]. Holländer E; Schwarczmann P Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966 [No Abstract] [Full Text] [Related]
10. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone]. Mugler A Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166 [No Abstract] [Full Text] [Related]
11. A comparison of phenylbutazone and flufenamic acid in the treatment of acute gout. Douglas G; Thompson M Ann Phys Med; 1970 May; 10(6):275-80. PubMed ID: 4913482 [No Abstract] [Full Text] [Related]
12. [Current etiopathogenetic and therapeutic views concerning gout and hyperuremic syndromes]. Ravera M Minerva Med; 1973 Jan; 64(4):144-56. PubMed ID: 4686682 [No Abstract] [Full Text] [Related]
13. [Clinical and biological effects of a new uric acid lowering substance (benziodaronum) in gout. Results of a 2-year-long study]. Barcelo P; Santamaria A Verh Dtsch Ges Rheumatol; 1969; 1():361-70. PubMed ID: 5403652 [No Abstract] [Full Text] [Related]
14. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Perez-Ruiz F; Calabozo M; Erauskin GG; Ruibal A; Herrero-Beites AM Arthritis Rheum; 2002 Dec; 47(6):610-3. PubMed ID: 12522834 [TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects of chronic gout]. Otto W; Binder E Z Gesamte Inn Med; 1966 Sep; 21(18):562-7. PubMed ID: 5990726 [No Abstract] [Full Text] [Related]
16. [Urinary uric acid excretion in patients with gout]. Eyman E; Sopata I Reumatologia; 1972; 10(3):197-204. PubMed ID: 4634598 [No Abstract] [Full Text] [Related]
18. [Uric acid clearance related to the use of an antirheumatic non-steroid drug]. Loizzi P; Carrozzo M; Pipitone V Minerva Med; 1973; 64(48):2568-75. PubMed ID: 4542205 [No Abstract] [Full Text] [Related]